E-LIB Suche - Ergebnisse für: Dahl, Göran

1

Discovery of the Potent and Selective Inhaled Janus Kinase ..:

Nilsson, Magnus ; Berggren, Kristina ; Berglund, Susanne...
Journal of Medicinal Chemistry. 66 (2023) 19 - p. 13400-13415 , 2023

Link: https://doi.org/10.1021/..

2

Characterization of Selective and Potent JAK1 Inhibitors In..:

Nilsson, Magnus ; Rhedin, Magdalena ; Hendrickx, Ramon...
Drug Design, Development and Therapy. 16 (2022) - p. 2901-2917 , 2022

Link: https://doi.org/10.2147/..

3

The Vital Role of Proteomics in Characterizing Novel Protei..:

Zhang, Andrew X. ; Cassidy, Katelyn ; Dahl, Göran...
SLAS Discovery. 26 (2021) 4 - p. 518-523 , 2021

Link: https://doi.org/10.1177/..

4

Regenerable Biosensors for Small-Molecule Kinetic Character..:

Gunnarsson, Anders ; Stubbs, Christopher J. ; Rawlins, Philip B....
SLAS Discovery. 26 (2021) 5 - p. 730-739 , 2021

Link: https://doi.org/10.1177/..

5

Macrocyclic Modalities Combining Peptide Epitopes and Natur..:

Guéret, Stéphanie M. ; Thavam, Sasikala ; Carbajo, Rodrigo J....
Journal of the American Chemical Society. 142 (2020) 10 - p. 4904-4915 , 2020

Link: https://doi.org/10.1021/..

6

Proteolysis‐targeting chimeras in drug development: A safet..:

Moreau, Kevin ; Coen, Muireann ; Zhang, Andrew X....
British Journal of Pharmacology. 177 (2020) 8 - p. 1709-1718 , 2020

Link: https://doi.org/10.1111/..

7

Inhibition of low-density lipoprotein receptor degradation ..:

Leitch, Eilidh K. ; Elumalai, Nagarajan ; Fridén-Saxin, Maria...
Chemical Science. 9 (2018) 27 - p. 5957-5966 , 2018

Link: https://doi.org/10.1039/..

8

Structure and biophysical characterization of the human ful..:

Sandmark, Jenny ; Dahl, Göran ; Öster, Linda...
Journal of Biological Chemistry. 293 (2018) 15 - p. 5492-5508 , 2018

Link: https://doi.org/10.1074/..

9

Unified Software Solution for Efficient SPR Data Analysis i..:

Dahl, Göran ; Steigele, Stephan ; Hillertz, Per...
SLAS Discovery. 22 (2017) 2 - p. 203-211 , 2017

Link: https://doi.org/10.1177/..

10

A comprehensive company database analysis of biological ass..:

Kramer, Christian ; Dahl, Göran ; Tyrchan, Christian.
Drug Discovery Today. 21 (2016) 8 - p. 1213-1221 , 2016

Link: https://doi.org/10.1016/..

11

Discovery of Second Generation Reversible Covalent DPP1 Inh..:

Doyle, Kevin ; Lönn, Hans ; Käck, Helena...
Journal of Medicinal Chemistry. 59 (2016) 20 - p. 9457-9472 , 2016

Link: https://doi.org/10.1021/..

12

Pharmacokinetics and the drug–target residence time concept:

Dahl, Göran ; Akerud, Tomas
Drug Discovery Today. 18 (2013) 15-16 - p. 697-707 , 2013

Link: https://doi.org/10.1016/..

13

Mechanistic and kinetic characterization of hepatitis C vir..:

Geitmann, Matthis ; Dahl, Göran ; Danielson, U. Helena
Journal of Molecular Recognition. 24 (2010) 1 - p. 60-70 , 2010

Link: https://doi.org/10.1002/..

14

Structure–activity relationships of HCV NS3 protease inhibi..:

Örtqvist, Pernilla ; Vema, Aparna ; Ehrenberg, Angelica E...
Antiviral Therapy. 15 (2010) 6 - p. 841-852 , 2010

Link: https://doi.org/10.3851/..

15

Hepatitis C Virus NS3 Protease Is Activated by Low Concentr..:

Dahl, Göran ; Arenas, Omar Gutiérrez ; Danielson, U. Helena
Biochemistry. 48 (2009) 48 - p. 11592-11602 , 2009

Link: https://doi.org/10.1021/..